The 2026 Stephens Investment Conference

11/18/2026 | 3:00pm EST

Webcast Link

The 38th Annual Piper Sandler Healthcare Conference

12/02/2026 | 12:30pm EST

Webcast Link

Events & Presentations

  • The 38th Annual Piper Sandler Healthcare Conference

    12/02/2026 | 9:30am PST / 12:30pm EST

    Watch the webcast

  • The 2026 Stephens Investment Conference

    11/18/2026 | 12:00pm PST / 3:00pm EST

    Watch the webcast

  • UBS Global Healthcare Conference

    11/10/2026 | 10:15am PST / 1:15pm EST

    Watch the webcast
View all events

Financial Reports and Filings

Date Filing Title Downloads
11/09/2026 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
11/09/2026 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
11/09/2026 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
11/09/2026 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
11/09/2026 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
11/09/2026 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
11/09/2026 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
11/09/2026 8-K Report of unscheduled material events or corporate event RTF XLS PDF HTML XBRL
11/06/2026 10-Q Quarterly report which provides a continuing view of a company's financial position RTF XLS PDF HTML XBRL
11/05/2026 8-K Report of unscheduled material events or corporate event RTF XLS PDF HTML XBRL
View all filings

Latest News

Myriad Genetics Reports Third Quarter 2026 Financial Results; Raises Mid-Point of Full-Year 2026 Revenue Guidance Following Solid Execution Definitive Agreement to Sell Prenatal Health Business to Support Strategic Growth Initiatives Thumbnail

Myriad Genetics Reports Third Quarter 2026 Financial Results; Raises Mid-Point of Full-Year 2026 Revenue Guidance Following Solid Execution Definitive Agreement to Sell Prenatal Health Business to Support Strategic Growth Initiatives

Nov 04, 2026 | Financial

Read more
Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences Thumbnail

Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences

Nov 02, 2026 | Financial

Read more
Myriad Genetics Releases New MONSTAR-SCREEN-3 Data Demonstrating the Potential of Ultra-Sensitive MRD Detection in Colorectal and Pancreatic Cancers Thumbnail

Myriad Genetics Releases New MONSTAR-SCREEN-3 Data Demonstrating the Potential of Ultra-Sensitive MRD Detection in Colorectal and Pancreatic Cancers

Oct 22, 2026 | Products

Read more
View all news releases

2025 Corporate Responsibility Report

Our Corporate Responsibility strategy reflects our vision for the future of healthcare. Building on more than 30 years of scientific leadership, we aim to invest with discipline and purpose. We are delivering insights that help people take control of their health and empower healthcare providers to better detect, treat, and prevent disease.

Read our 2025 Corporate Responsibility report to learn how we are working to advance innovation, strengthen our impact, and support the creation of long-term value for patients, providers, employees, and the communities we serve.

Read the report
2025 Corporate Responsibility Report

2025 Corporate Responsibility Report

Our Corporate Responsibility strategy reflects our vision for the future of healthcare. Building on more than 30 years of scientific leadership, we aim to invest with discipline and purpose. We are delivering insights that help people take control of their health and empower healthcare providers to better detect, treat, and prevent disease.

Read our 2025 Corporate Responsibility report to learn how we are working to advance innovation, strengthen our impact, and support the creation of long-term value for patients, providers, employees, and the communities we serve.

Read the report
2025 Corporate Responsibility Report